Linde Q2 2026: Adjusted EPS $4.50 Beats Consensus, Full-Year Guidance Raised to $17.70–$17.90
LIN sits 23% above its 52-week low of $387.78.
Summary
Linde posted Q2 adjusted EPS of $4.50, beating estimates, and raised full-year guidance. Sales grew 9% on strong pricing and volumes, while the company continued heavy share repurchases.
Key Events · Earnings and Guidance · LIN
-
Q2 Earnings Beat
Adjusted diluted EPS of $4.50 exceeded the $4.48 consensus. Reported net income rose 9% to $1.93 billion.
-
Full-Year Guidance Raised
Management lifted the lower end of 2026 adjusted EPS guidance to $17.70–$17.90, up from the prior $17.60–$17.90 range.
-
Revenue Growth Broad-Based
Sales increased 9% to $9.3 billion, with 2% from higher pricing, 2% from volume growth, and 2% from currency tailwinds.
-
Semiconductor Supply Win
Linde secured a long-term agreement to supply ultra-high-purity industrial gases to a top semiconductor manufacturer, bolstering its electronics exposure.
Analysis · LIN · Industrial Applications And Services
Linde delivered a strong second quarter, with adjusted earnings per share of $4.50 topping the $4.48 consensus. Sales rose 9% to $9.3 billion, driven by higher pricing and volumes in electronics and manufacturing. Management raised the lower end of full-year guidance to $17.70–$17.90, signaling confidence in sustained demand. The quarter also saw a new long-term semiconductor supply agreement and continued aggressive share buybacks, with $1.7 billion repurchased in the first half. The results reinforce Linde's position as a high-quality industrial compounder, though the stock's premium valuation means the beat is largely priced in.
At the time of this filing, LIN was trading at $476.61 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $220.5B. The 52-week trading range was $387.78 to $548.20. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.